Sending general practitioners (GPs) in England a letter giving feedback on their antibiotic prescribing habits could cut unnecessary prescriptions of antibiotics, according to the first nationwide randomised trial of its ...
Feb 19, 2016
0
0
Zika virus has been detected in the amniotic fluid of two pregnant women whose foetuses had been diagnosed with microcephaly, according to a study published today in The Lancet Infectious Diseases. The report suggests that ...
Feb 18, 2016
0
59
To help healthcare professionals, medical researchers and the public understand the ongoing outbreak of the Zika virus, Elsevier has created a Zika Virus Resource Center on Elsevier Connect, Elsevier's public news and information ...
Feb 10, 2016
0
1
HIV drug resistance to tenofovir, an antiretroviral drug vital to most modern HIV treatment and prevention strategies, is surprisingly and worryingly common according to a large study led by UCL (University College London) ...
Jan 28, 2016
0
33
More than 2.6 million stillbirths continue to occur globally every year with very slow progress made to tackle this 'silent problem', according to new research published in The Lancet. Despite significant reductions in the ...
Jan 18, 2016
0
11
Scientists have discovered that a commonly prescribed dementia drug could hold the key to helping prevent debilitating falls for people with Parkinson's.
Jan 13, 2016
1
11
People with depression, that have not responded fully to treatment with antidepressants, benefit from receiving additional cognitive behavioural therapy (CBT), a new study has found.
Jan 7, 2016
0
38
Specialists at The Christie and The University of Manchester have made a breakthrough which will spare patients with cancer of the lower bowel, rectal cancer, from major surgery.
Dec 17, 2015
0
1
A paper published in The Lancet today calls for a radical transformation in the architecture of India's healthcare delivery system, if the country is to achieve the government's vision of assuring health for all.
Dec 11, 2015
0
1
The results of a phase 3 randomised controlled trial, published today in The Lancet, show that, despite being safe to administer, there is no benefit in using the probiotic Bifidobacterium breve (BBG-001) to prevent late-onset ...
Nov 26, 2015
0
1
